EUVIMEDEUVIMED entdecken
Crossref

A Four-Year Silence: Late-Onset Stent-Graft Endocarditis Due to Rare Enterobacter hormaechei Diagnosed via Transesophageal Echocardiography

Mustafa Atakan Karabaş

JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH · 30.04.2026 · 10 (1) · 58-62

DOI: 10.34084/bshr.1883574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH, online erschienen am 30.04.2026. Verfasst von Mustafa Atakan Karabaş. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stent-graft infection (SGI) after thoracic endovascular aortic repair (TEVAR) is a rare but life-threatening complication. We report a case of a male patient who presented four years after TEVAR with systemic sepsis. At admission, laboratory investigations revealed a marked inflammatory response with a C-reactive protein (CRP) level of 212 mg/dL and a procalcitonin level of 23.30 progression. Diagnostic workup identified multidrug-resistant (MDR) Enterobacter hormaechei bacteremia. While transthoracic imaging was inconclusive, transesophageal echocardiography (TEE) confirmed a 6.6 x 5 mm mobile, fibrillar vegetation on the luminal surface of the aortic stent-graft, accompanied by severe aortic regurgitation. Following susceptibility results, the initial trimethoprim/sulfamethoxazole treatment was discontinued, and targeted intravenous gentamicin was initiated. Following the switch to gentamicin, a prompt therapeutic response was achieved, and inflammatory markers showed a significant downward trend. After multidisciplinary evaluation with the cardiovascular surgery department, a conservative management approach was adopted due to high operative risk. The patient remains under stable clinical follow-up. This case underscores the diagnostic necessity of TEE and the importance of targeted aminoglycosides in managing late-onset MDR prosthetic infections, especially when surgical intervention is not feasible.

Zitieren

APA

Karabaş, M. A. (2026). A Four-Year Silence: Late-Onset Stent-Graft Endocarditis Due to Rare Enterobacter hormaechei Diagnosed via Transesophageal Echocardiography. JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH, 10(1), 58-62. https://doi.org/10.34084/bshr.1883574

Vancouver

Karabaş MA. A Four-Year Silence: Late-Onset Stent-Graft Endocarditis Due to Rare Enterobacter hormaechei Diagnosed via Transesophageal Echocardiography. JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH. 2026;10(1):58-62. doi:10.34084/bshr.1883574

BibTeX
@article{Karaba2026,
  author = {Karabaş, Mustafa Atakan},
  title = {A Four-Year Silence: Late-Onset Stent-Graft Endocarditis Due to Rare Enterobacter hormaechei Diagnosed via Transesophageal Echocardiography},
  journal = {JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {58--62},
  doi = {10.34084/bshr.1883574}
}
Kostenlos starten →